Peng Li,Qiang Zhang,Robert Davis,Lawrence P. Wennogle
申请号：
US14777466
公开号：
US09708322B2
申请日:
2014.03.15
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention relates to substituted heterocycle fused gamma-carbolines of the Formula Q as described herein, in free base or pharmaceutically acceptable salt form, and/or pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving the 5-HT2A receptor pathway, the serotonin transporter (SERT) pathway and/or the dopamine D2 receptor pathway signaling systems.
